CN102631426A - Traditional Chinese medicine composition for treating anaphylactoid purpura - Google Patents
Traditional Chinese medicine composition for treating anaphylactoid purpura Download PDFInfo
- Publication number
- CN102631426A CN102631426A CN2012101342488A CN201210134248A CN102631426A CN 102631426 A CN102631426 A CN 102631426A CN 2012101342488 A CN2012101342488 A CN 2012101342488A CN 201210134248 A CN201210134248 A CN 201210134248A CN 102631426 A CN102631426 A CN 102631426A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- medicine composition
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a traditional Chinese medicine composition for treating anaphylactoid purpura. The traditional Chinese medicine composition is prepared by indigo naturalis, radix scutellariae, plant soot, calamitas urinae hominis, buffalo horn, macleaya cordata, salvia miltiorrhiza, rhizoma corydalis, trogopterus dung and rhubarb and can be clinically used for treating the anaphylactoid purpura.
Description
Technical field
The invention belongs to technical field of Chinese medicines, especially relate to a kind of Chinese medicine composition of treating anaphylactoid purpura.
Background technology
Purpura belongs to categories such as the traditional Chinese medical science " purpura ", " hematohidrosis ".Mostly its cause of disease is the heresy of affection due to external wind and heat, and the damp and hot poison of holding under the arm accumulates and hinders in flesh table blood system, and the absurd row of forcing blood, so that escape of blood from meridians overflow outside arteries and veins, ooze between skin, then see purpura; Or due to illness feelings delay, the QI and blood consumption is hindered, and undermines the spleen kidney, makes the deficiency of vital energy can not take the photograph blood, the insufficiency of the spleen blood of can not uniting, so that outside the blood oozing from the body openings or subcuta neous tissue arteries and veins, stay between the muscle internal organs and purpura occurs, have blood in stool, hematuria.Treated anaphylactoid purpura single western medicine therapy commonly used, but effect is not satisfactory, process inventor's long-term practice draws in the past, and Chinese medicine is controlled anaphylactoid purpura and had better effect, obtains good effect.
Summary of the invention
The object of the present invention is to provide that a kind of therapeutic effect is good, effective percentage is high, to the Chinese medicine composition of the treatment anaphylactoid purpura of human non-toxic side effect.
The objective of the invention is to realize like this; According to Chinese medical theory; Utilize the unique property of medicine of Chinese medicine, adopt Indigo Naturalis, Radix Scutellariae, Pulvis Fumi Carbonisatus, calamitas urinae hominis, Cornu Bubali, Herba Macleayae Cordatae, Radix Salviae Miltiorrhizae, Rhizoma Corydalis, Oletum Trogopterori, Radix Et Rhizoma Rhei according to certain compatibility requirement, through being processed into.
Prepare Chinese medicine composition of the present invention and process Indigo Naturalis 30-50 part, Radix Scutellariae 30-50 part, Pulvis Fumi Carbonisatus 30-50 part, calamitas urinae hominis 20-40 part, Cornu Bubali 20-40 part, Herba Macleayae Cordatae 20-40 part, Radix Salviae Miltiorrhizae 20-40 part, Rhizoma Corydalis 10-30 part, Oletum Trogopterori 10-30 part, the 10-30 of Radix Et Rhizoma Rhei part by following raw material medicaments.
Optimum weight part of traditional Chinese medicinal composition raw materials of the present invention is: 40 parts of Indigo Naturaliss, 40 parts of Radix Scutellariaes, 40 parts of Pulvis Fumi Carbonisatuss, 30 parts of calamitas urinae hominises, 30 parts of Cornu Bubalis, 30 parts of Herba Macleayae Cordatae, 30 parts of Radix Salviae Miltiorrhizaes, 20 parts of Rhizoma Corydalis, 20 parts of Oletum Trogopteroris, 20 parts in Radix Et Rhizoma Rhei.The pharmacological action of Chinese medicine of the present invention is following:
Indigo Naturalis: salty, cold.Return liver, lung, stomach warp.Heat-clearing and toxic substances removing, cooling blood for hemostasis, purging liver-fire.Be used for the epidemic febrile disease maculopapulae due to toxic heat, heat in blood is spitted blood, epistaxis, spitting of blood, liver-heat infantile convulsion, liver-fire invading the lung cough, laryngopharynx swelling and pain etc.
Radix Scutellariae: bitter, cold, attach to the lung and stomach meridians.Heat clearing and damp drying, eliminating fire and detoxication.Be used for carbuncle sore tumefacting virus outward, damp and hot painful abdominal mass is vexed.
Pulvis Fumi Carbonisatus: bitter, hot, warm.Return liver, lung, stomach warp.Hemostasis, removing food stagnancy, sterilizing powdered medicine fire.Be used for spitting blood, epistaxis is had blood in stool, metrorrhagia, leukorrhagia, food stagnation, laryngopharynx swelling and pain, aphtha of the mouth and tongue, traumatic hemorrhage etc.
Calamitas urinae hominis: salty, cool.Return lung, the heart, urinary bladder channel.Resolving heat and reducing pathogenic fire; Hemostasia and dissipation blood stasis.Cure mainly the consumptive lung disease consumptive fever, spit blood, epistaxis, sore throat, aphtha of the mouth and tongue, all wetting festered burn and scald etc.
Cornu Bubali: bitter, salty, cold.GUIXIN, Liver Channel.Heat clearing away, detoxifcation, removing heat from blood, arresting convulsion.Be used for the calentura headache, discuss hot coma, send out the speckle dermexanthesis, stagnant heat jaundice, infantile convulsion and laryngopharynx swelling and pain, aphtha of the mouth and tongue etc.
Herba Macleayae Cordatae: hot, bitter, cold, very toxic.GUIXIN, liver, stomach warp.Dissipating blood stasis; Dispel the wind; Detoxifcation; Pain relieving; Parasite killing.It is swollen to cure mainly pain skin ulcer furuncle, ecthyma, hemorrhoid, eczema, snake bite and insect sting, treating swelling and pain by traumatic injury, rheumatic arthritis, caries pain, stubborn dermatitis, trichomonal vaginitis and wine (looking into skin) nose.
Radix Salviae Miltiorrhizae: bitter, be slightly cold.GUIXIN, Liver Channel.Promoting blood flow to regulate menstruation, the removing heat from blood eliminating carbuncle is calmed the nerves.The ambition, epigastric pain that are used for blood stasis is Ji lumps in the chest and abdomen, rheumatic arthralgia, skin infection carbuncle etc.
Oletum Trogopterori: bitter, salty, sweet, temperature.Return Liver Channel.Promoting blood circulation and stopping pain, removing stasis to stop bleeding.Be used for all cards of stagnation of blood stasis.
Radix Et Rhizoma Rhei: bitter, cold.Return stomach, large intestine, liver, spleen channel.Have attack stagnant, clearing away damp-heat, pathogenic fire purging, removing heat from blood, blood stasis dispelling, antidotal effect.Be used for the excess-heat constipation, the accumulation of heat feeling of stuffiness in chest, damp-heat dysentery, jaundice, gonorrhea, edema abdominal distention, dysuria, conjunctival congestion etc.
Indigo Naturalis, Radix Scutellariae, Pulvis Fumi Carbonisatus, calamitas urinae hominis have heat-clearing and toxic substances removing, the effect of removing heat from blood repercussive among the present invention, and four medicines share and are monarch drug, and Herba Macleayae Cordatae, Radix Salviae Miltiorrhizae, Rhizoma Corydalis, Oletum Trogopterori are invigorated blood circulation, collateral dredging, dissipating blood stasis, Radix Et Rhizoma Rhei, Cornu Bubali clearing away damp-heat, pathogenic fire purging, removing toxicity for eliminating carbuncles.Find that through clinical practice anaphylactoid purpura is had unique curative effect, the effect that all medicines are played clearing away heat and cooling blood, promoting blood circulation to remove blood stasis, eliminating dampness and diuresis altogether reaches the purpose of treating anaphylactoid purpura.
Chinese medicine composition of the present invention was in 2006 to 2011 clinical observation anaphylactoid purpura 120 routine patients, and clinical report is following:
1, physical data
Among the 120 routine patients, age 17-29 year, the course of disease is many at 3 months to 2 years, 24 years old mean age.
2, diagnostic criteria
" traditional Chinese medical science disease diagnosis criterion of therapeutical effect " that diagnosis basis State Administration of Traditional Chinese Medicine issues:
Disease sees that ecchymosis appears in general skin, differs in size, and new petechia color is red, and ecchymosis is livid purple, with buttocks and extremity comparatively dense.Touching is not in the way, and that presses does not fade, and skin does not have gargalesthesia, constipation with dry stool, and abdominal pain with tenderness, listless, thirst and liking drink, implication is smelly, the oliguria yellow skin, body of the tongue is red, yellow and thin fur and be bored with rapid pulse.
3, Therapeutic Method
3.1 prescription: Indigo Naturalis 40g, Radix Scutellariae 40g, Pulvis Fumi Carbonisatus 40g, calamitas urinae hominis 30g, Cornu Bubali 30g, Herba Macleayae Cordatae 30g, Radix Salviae Miltiorrhizae 30g, Rhizoma Corydalis 20g, Oletum Trogopterori 20g, the 20g of Radix Et Rhizoma Rhei.
3.2 preparation and method for using: said medicine is processed decoction by common process, and 1 dose of every day, every day 2 times, 10 days was 1 course of treatment.
4, therapeutic outcome:
4.1 formulate with reference to " Chinese medicine Clinical Researches of New Drugs guideline ":
Recovery from illness: the symptom complete obiteration, clinical laboratory's no albuminuria of inspection and hematuria, and do not have recurrence in half a year;
Produce effects: symptom and test rating obviously improve, and do not have recurrence in 2 months;
Invalid: symptom and test rating do not have obvious improvement.
4.2 result: among the 120 routine patients, clinical cure 83 examples (69.2%), produce effects 31 examples (25.8%), invalid 6 examples (5%), total effective rate is 95%.
Model case
1, grandson, the man, 17 years old, the ecchymosis color was pale purple, shallow complexion, the lazy short speech of gas, diet is not good enough, with disease such as dizzy, that nose is bled, light red tongue, body is loose, and thready pulse is heavy unable.Take medicine of the present invention, treat 2 courses of treatment, symptom obviously alleviates, and continues to take 1 course of treatment, and recovery from illness is followed up a case by regular visits to after half a year and do not had recurrence.
2, Zhang, the woman, 28 years old, lusterless complexion, hair is withered, and fear heat is irritated, and extremities joint is ached, and is hard and dry, and two lower limb, the visible symmetrical distribution purpura of buttocks are not of uniform size, and be colour-fast by it, red tongue, wiry and frequent pulse.Take medicine of the present invention, 1 dose of every day, after 2 courses of treatment, symptom is clearly better, and continues to take 2 courses of treatment, and recovery from illness is followed up a case by regular visits to after 1 year and do not had recurrence.
The specific embodiment
Below in conjunction with embodiment the present invention is further described, following this embodiment only is used to the present invention is described and the present invention is not limited.
Embodiment 1, and a kind of Chinese medicine composition of treating anaphylactoid purpura is to be processed by Indigo Naturalis 30g, Radix Scutellariae 30g, Pulvis Fumi Carbonisatus 30g, calamitas urinae hominis 20g, Cornu Bubali 20g, Herba Macleayae Cordatae 20g, Radix Salviae Miltiorrhizae 20g, Rhizoma Corydalis 10g, Oletum Trogopterori 10g, the 10g of Radix Et Rhizoma Rhei.
Embodiment 2, and a kind of Chinese medicine composition of treating anaphylactoid purpura is to be processed by Indigo Naturalis 40g, Radix Scutellariae 40g, Pulvis Fumi Carbonisatus 40g, calamitas urinae hominis 30g, Cornu Bubali 30g, Herba Macleayae Cordatae 30g, Radix Salviae Miltiorrhizae 30g, Rhizoma Corydalis 20g, Oletum Trogopterori 20g, the 20g of Radix Et Rhizoma Rhei.
Embodiment 3, and a kind of Chinese medicine composition of treating anaphylactoid purpura is to be processed by Indigo Naturalis 50g, Radix Scutellariae 50g, Pulvis Fumi Carbonisatus 50g, calamitas urinae hominis 40g, Cornu Bubali 40g, Herba Macleayae Cordatae 40g, Radix Salviae Miltiorrhizae 40g, Rhizoma Corydalis 30g, Oletum Trogopterori 30g, the 30g of Radix Et Rhizoma Rhei.
Claims (2)
1. a Chinese medicine composition of treating anaphylactoid purpura is characterized in that it is to be processed by following raw material medicaments: Indigo Naturalis 30-50 part, Radix Scutellariae 30-50 part, Pulvis Fumi Carbonisatus 30-50 part, calamitas urinae hominis 20-40 part, Cornu Bubali 20-40 part, Herba Macleayae Cordatae 20-40 part, Radix Salviae Miltiorrhizae 20-40 part, Rhizoma Corydalis 10-30 part, 10～30 parts of Oletum Trogopteroris, the 10-30 of Radix Et Rhizoma Rhei part.
2. Chinese medicine composition according to claim 1 is characterized in that it is to be processed by following raw material medicaments: 40 parts of Indigo Naturaliss, 40 parts of Radix Scutellariaes, 40 parts of Pulvis Fumi Carbonisatuss, 30 parts of calamitas urinae hominises, 30 parts of Cornu Bubalis, 30 parts of Herba Macleayae Cordatae, 30 parts of Radix Salviae Miltiorrhizaes, 20 parts of Rhizoma Corydalis, 20 parts of Oletum Trogopteroris, 20 parts in Radix Et Rhizoma Rhei.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012101342488A CN102631426A (en) | 2012-04-19 | 2012-04-19 | Traditional Chinese medicine composition for treating anaphylactoid purpura |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012101342488A CN102631426A (en) | 2012-04-19 | 2012-04-19 | Traditional Chinese medicine composition for treating anaphylactoid purpura |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102631426A true CN102631426A (en) | 2012-08-15 |
Family
ID=46616105
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012101342488A Pending CN102631426A (en) | 2012-04-19 | 2012-04-19 | Traditional Chinese medicine composition for treating anaphylactoid purpura |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102631426A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104547708A (en) * | 2015-01-19 | 2015-04-29 | 孙宁 | Traditional Chinese medicine for treating anaphylactoid purpura |
| CN104623290A (en) * | 2015-01-09 | 2015-05-20 | 付传英 | Traditional Chinese medicine for treating anaphylactoid purpura caused by fire excess from Yin deficiency |
| CN104971231A (en) * | 2015-07-09 | 2015-10-14 | 宋永欣 | Traditional Chinese medicine composition for treating anaphylactoid purpura and preparation method of traditional Chinese medicine composition |
-
2012
- 2012-04-19 CN CN2012101342488A patent/CN102631426A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104623290A (en) * | 2015-01-09 | 2015-05-20 | 付传英 | Traditional Chinese medicine for treating anaphylactoid purpura caused by fire excess from Yin deficiency |
| CN104547708A (en) * | 2015-01-19 | 2015-04-29 | 孙宁 | Traditional Chinese medicine for treating anaphylactoid purpura |
| CN104971231A (en) * | 2015-07-09 | 2015-10-14 | 宋永欣 | Traditional Chinese medicine composition for treating anaphylactoid purpura and preparation method of traditional Chinese medicine composition |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103861046B (en) | One treats prosopalgic Chinese medicine | |
| CN105662996A (en) | Traditional Chinese medicine mask for treating menstruation-associated acne | |
| CN104906465A (en) | Traditional Chinese medicine blood-stasis dispersing composition for treating woman chronic pelvic inflammation and preparation method thereof | |
| CN105106797A (en) | Traditional Chinese medicine nursing composition for treating tenosynovitis | |
| CN102631426A (en) | Traditional Chinese medicine composition for treating anaphylactoid purpura | |
| CN103610915B (en) | Traditional Chinese medicine for treating swelling and pain in throat | |
| CN103316239A (en) | Traditional Chinese medicine for treating anaphylactoid purpura | |
| CN104984148A (en) | Traditional Chinese medicine composite for wound care in clinical application | |
| CN104547936A (en) | Traditional Chinese medicine for treating local induration of vascular access of hemodialysis patient | |
| CN101274045B (en) | Exterior-applied medicament for treating psoriasis | |
| CN104857084A (en) | Traditional Chinese medicine medicated bath preparation for treating infantile exogenous fever | |
| CN103768317A (en) | Traditional Chinese medicinal composition for treating biliary tract ascariasis | |
| CN103948711B (en) | A kind of Chinese medicine ointment of controlling empyrosis non-healing wounds | |
| CN102579607A (en) | Chinese medicine composition for treating acne | |
| CN106038905A (en) | Narcotic analgesic and preparation method thereof | |
| CN104771498A (en) | Traditional Chinese medicine composition for treating mumps caused by accumulated toxic heat | |
| CN104257967A (en) | Traditional Chinese medicine for treating sports injury | |
| CN104547359A (en) | Traditional Chinese medicine composition for treating spleen deficiency and dampness stagnation type eczema | |
| CN104587071A (en) | Traditional Chinese medicament for treating infantile blood-heat allergic purpura | |
| CN104740111A (en) | Traditional Chinese medicine for treating qi-stagnation blood-stasis type dysmenorrhea | |
| CN103566308A (en) | Traditional Chinese medicine for treating primary dysmenorrhea | |
| CN104225293A (en) | Traditional Chinese medicine disinfectant solution for clinical laboratory | |
| CN103495050B (en) | Chinese medicinal composition for treating blood-heat stasis type acne | |
| CN103948872A (en) | Traditional Chinese medicinal formula for treating psoriatic arthritis | |
| CN104161821A (en) | Traditional Chinese medicine liniment for promoting blood circulation to remove meridian obstruction |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20120815 |